NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-216-2014-0-AR-02 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES AR ORD 20160103793 Pending
NIAID E-216-2014-0-EP-13 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES EP National Stage 16822321.2 Pending
NIAID E-037-2016-0-AU-03 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS AU National Stage 2016366768 Abandoned
NIAID E-216-2014-0-CA-06 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES CA National Stage 3007408 Pending
NIAID E-037-2016-0-CA-04 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS CA National Stage 3007474 Abandoned
NIAID E-195-2014-0-US-06 Polyvalent Influenza Virus-Like Particles (VLPS) And Use As Vaccines US National Stage 15/317,593 10130700 Issued PDF
NIBIB E-158-2015-0-PCT-02 VESICLE CONTAINING METALLIC NANOPARTICLE AND METHOD FOR PRODUCTION THEREOF PCT PCT PCT/US2016/065708 Expired
NINDS E-130-2022-0-US-01 Oxabicycloheptanes for Modulation of CTLA-4 Activity US 62/497,949 Expired
NCI E-132-2016-1-US-01 Use Of Heterodimeric IL-15 In Adoptive Cell Transfer US 62/497,948 Abandoned
NCI E-042-2014-0-NZ-12 Chimeric Antigen Receptors Targeting CD-19 NZ National Stage 727167 Issued
NCI E-508-2013-2-US-11 Inhibitors of the Farnesoid X Receptor and Uses in Medicine US DIV 15/371,032 10233209 Issued PDF
NIDCR E-142-2011-0-US-06 AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subjects from Diabetes or Obesity US DIV 15/368,940 10300095 Issued PDF
NCATS E-073-2017-0-US-01 Zika Virus NS-1 Inhibitors For Treatment Of Zika Virus Infection US 62/430,107 Abandoned
NCI E-099-2014-0-US-08 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF US National Stage 15/368,278 10633441 Issued PDF
NCI E-003-2007-0-US-23 ENGINEERED ANTIBODY CONSTANT DOMAIN MOLECULES US DIV 15/367,488 10358481 Issued PDF
NHLBI E-217-2015-0-PCT-02 Fluorescent Nanodiamonds For Use As Fiducial Markers For MicroscopY And Fluorescence Imaging PCT PCT PCT/US2016/064523 Expired
NHLBI E-217-2015-0-CN-07 Fluorescent Nanodiamonds For Use As Fiducial Markers For MicroscopY And Fluorescence Imaging CN National Stage 2016800703856 Abandoned
NHLBI E-217-2015-0-EP-04 Fluorescent Nanodiamonds For Use As Fiducial Markers For MicroscopY And Fluorescence Imaging EP National Stage 16871544.9 Abandoned
NHLBI E-217-2015-0-JP-05 Fluorescent Nanodiamonds For Use As Fiducial Markers For MicroscopY And Fluorescence Imaging JP National Stage 2018-528955 Abandoned
NHLBI E-217-2015-0-AU-03 Fluorescent Nanodiamonds For Use As Fiducial Markers For MicroscopY And Fluorescence Imaging AU National Stage 2016362397 Abandoned
NCI E-209-2014-0-SG-08 PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO SG National Stage 11201610052T Issued
NCI E-042-2014-0-IL-07 Chimeric Antigen Receptors Targeting CD-19 IL National Stage 249305 Issued
NCI E-039-2011-0-CA-04 Chimeric Rabbit/Human ROR1 Antibodies CA National Stage 2818992 Issued
NCI E-176-2014-0-KR-10 Anti-Human Papillomavirus 16 E7 T Cell Receptors KR National Stage 10-2016-7033189 Issued
NCI E-213-2014-0-EP-04 Methodology For Astatination And Radioiodination Based On Iodonium Salt Precursors EP National Stage 16801234.2 Issued
NCI E-213-2014-0-AU-03 Methodology For Astatination And Radioiodination Based On Iodonium Salt Precursors AU National Stage 2016360886 Issued
NCI E-213-2014-0-PCT-02 METHOD FOR SYNTHESIZING IODO- OR ASTATOARENES USING DIARYLIODONIUM SALTS PCT PCT PCT/EP2016/078729 Expired
NCATS E-004-2016-0-GB-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF GB EP 22162126.1 Issued
NCATS E-004-2016-0-EP-10 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF EP DIV 22162126.1 Issued
NCATS E-004-2016-0-DE-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF DE EP 22162126.1 Issued
NCATS E-004-2016-0-IE-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF IE EP 22162126.1 Issued
NCATS E-004-2016-0-FR-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF FR EP 22162126.1 Issued
NCATS E-004-2016-0-ES-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF ES EP 22162126.1 Issued
NCATS E-004-2016-0-IT-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF IT EP 22162126.1 Issued
NCATS E-004-2016-0-CA-04 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF CA National Stage 3006300 Issued
NCATS E-004-2016-0-HK-11 BICYCLIC BET BROMODOMAIN INHIBITORS AND USES THEREOF HK EP 19121881.7 Issued
NCATS E-004-2016-0-EP-06 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF EP National Stage 16810193.9 Issued
NCATS E-004-2016-0-AU-03 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF AU National Stage 2016361441 Issued
NCI E-176-2014-0-US-13 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS US National Stage 15/313,673 10174098 Issued PDF
NCATS E-004-2016-0-PCT-02 BICYCLIC BET BROMODOMAIN INHIBITORS AND USES THEREOF PCT PCT PCT/US2016/063485 Expired
NCATS E-004-2016-0-HK-01 BICYCLIC BET BROMODOMAIN INHIBITORS AND USES THEREOF HK EP 42023068303.9 Pending
NCI E-289-2011-0-US-17 YEAST-MUC1 IMMUNOTHERAPEUTIC COMPOSITIONS AND USES THEREOF US DIV 15/358,797 10188714 Issued PDF
NIAID E-226-2011-0-US-05 MONOCLONAL ANTIBODIES THAT NEUTRALIZE A NOROVIRUS US DIV 15/359,438 9815887 Issued PDF
NCI E-141-2008-0-JP-31 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof JP DIV 2016-226503 Abandoned
NCI E-025-2017-0-US-01 ANTI-MAGE-A3/A6 ANTIBODIES, POLYPEPTIDES, AND PROTEINS US 62/425,231 Abandoned
NICHD E-259-2014-1-US-02 Magnetic Resonance 2D Relaxometry Reconstruction Using Partial Data US National Stage 15/312,162 10613176 Issued PDF
NCI E-210-2016-0-US-01 Multispecific Antibodies To HIV-1 ENV and CD3 And Their Use US 62/423,617 Abandoned
NIAID E-086-2018-0-US-01 Zika Viral Antigen Constructs US 62/423,398 Abandoned
CC E-136-2016-0-US-01 Imageable Particles, Methods of Making and Methods of Use Thereof US 62/422,972 Abandoned
NIAID E-070-2014-0-US-03 Treatment or Prevention of an Intestinal Disease or Disorder US National Stage 15/311,405 10058559 Issued PDF